Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Diabetic Retinopathy - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Retinopathy market report provides current treatment practices, emerging drugs, Diabetic Retinopathy market share of the individual therapies, current and forecasted Diabetic Retinopathy ... Read More
-
Insulin Glargine- - Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Diabetic Socks Market Share, Size, Trends, Industry Analysis Report, By Product (Ankle Length, Calf length, Knee length), By Distribution Channel (Hypermarkets, Pharmacy & Drug stores, E-commerce, Others), By Region; Segment Forecast, 2022 - 2030
... global diabetic socks market size is expected to reach USD 285.2 million by 2030 according to a new study by Polaris Market Research. The report “Diabetic Socks Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
Diabetic Food Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis
... according to the World Health Organization (WHO), in 2021, 463 million people exist with diabetes globally. By 2045, this number will increase to some 700 million diabetics globally. Lifestyle and dietary modes play an important ... Read More
-
Human Microbiome Market - By Product (Probiotics, Prebiotics, Medical Foods, And Supplements), By Application (Therapeutics And Diagnostics) And By Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, And Cancer): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021 – 2030
... Analysis And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Human Microbiome Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According ... Read More
-
Diabetic Retinopathy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Retinopathy Understanding The DelveInsight Diabetic Retinopathy ... Read More
-
Type 2 Diabetes - Market Insight, Epidemiology and Market Forecast -2032
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Type 2 Diabetes market report provides current treatment practices, emerging drugs, Type 2 Diabetes market share of the individual therapies, ... Read More
-
Dementia with Diabetes - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Dementia with Diabetes Understanding The ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Diabetes Pen - Market Insights, Competitive Landscape and Market Forecast-2026
... End User (Hospitals & Clinics, Homecare Settings, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancements in product development and increasing prevalence of diabetes. ... Read More
-
Diabetic Gastroparesis - Epidemiology Forecast-2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Gastroparesis Understanding The DelveInsight Diabetic Gastroparesis ... Read More
-
Diabetic Macular Edema (DME) - Market Insight, Epidemiology and Market Forecast -2032
... (DME) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Macular Edema (DME) market report provides current treatment practices, emerging drugs, Diabetic Macular Edema (DME) market ... Read More
-
Diabetic Macular Edema (DME) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Macular Edema ... Read More
-
Insulin Resistance - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Insulin Resistance Understanding The DelveInsight Insulin Resistance ... Read More
-
Smart Insulin Pens- Market Insights, Competitive Landscape and Market Forecast–2026
... forecasted Smart Insulin Pens market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Smart Insulin Pens market report provides an overview of Smart Insulin Pens, applications of Smart Insulin Pens as ... Read More
-
Diabetes - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Diabetes market report provides current treatment practices, emerging drugs, Diabetes market share of the individual therapies, current and forecasted Diabetes market Size from 2019 to 2032 ... Read More
-
Diabetic Neuropathy - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Neuropathy market report provides current treatment practices, emerging drugs, Diabetic Neuropathy market share of the individual therapies, current and forecasted Diabetic Neuropathy ... Read More
-
Diabetic Nephropathy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Nephropathy Understanding The DelveInsight Diabetic Nephropathy ... Read More
-
Type 2 Diabetes - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Type 2 Diabetes Understanding The ... Read More
-
Diabetic Foot Ulcers (DFUs) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Foot Ulcers ... Read More
-
Diabetic Foot - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Foot Understanding The DelveInsight Diabetic Foot ... Read More
-
The Market for In Vitro Diagnostic Tests in Latin America
... (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are ... Read More
-
Diabetic Retinopathy (DR)
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward
... of diabetes amongst the developed nations. In 2018, ~2.4m people in the US had DME, of that only ~70% got diagnosed and treated. Following is the current treatment paradigm for DME - the first line ... Read More
-
Syndicated Quarterly Diabetes Market Share Tracker Europe
... sizes and market share by brand with NPS score. Includes drivers and barriers, types of usage and patient preferences, brand attributes ranking, plus country-specific reimbursement landscape and changes, digital health/diabetes apps chapter. In it's fourth ... Read More
Research Assistance
